(Redirected from Gestageny)
Gestagens (progestins) are a group of female sex hormones with antiestrogenic and antigonadotropic effects. The most important is progesterone.
Progesterone[edit | edit source]
It is formed in the corpus luteum of ovaries and placenta (after 6-8 weeks of pregnancy; 30-40 times more), as an intermediate product in the synthesis of androgens and estrogens also in the adrenal cortex and in small amounts in the testes.
It is synthesized from cholesterol via the intermediate product pregnenolone, from which it differs in the A-ring arrangement.
It binds to the protein carrier in plasma. It is rapidly metabolized in the liver – it has a very low biological availability and a short half-time. Progesterone is p.o. ineffective due to active metabolism in the liver.
After conjugation with glucuronic acid (inactivation) in the liver, it is excreted in the urine as pregnanediol.
Effects[edit | edit source]
Progestins lead to:
- development of secretory tissues in the mammary glands (acins) – lactation is blocked and begins only after delivery (sharp drop in progesterone levels), maintained by the hormone prolactin
- endometrial maturation in the second half of the menstrual cycle – transition from proliferative to secretory phase (increase in the volume and size of glandular secretion and increase of glycogen amount) -> preparation of the uterine lining for egg acceptance + throat narrowing and cervical mucus compaction.
- reducing the effects of estrogens on the vaginal wall
- affecting peripheral blood flow – reduce heat loss, increase body temperature (on average by 0,5 °C during the luteal phase of the cycle – ovulation indicator)
Compared to estrogens they have a minimal effect on the composition of plasma proteins (they do not affect plasma fibrinogen levels). They significantly affect sugar metabolism and stimulate fat storage.
Gestagens and estrogens act synergistically - estrogens initiate the formation of progesterone receptors.
Clinical use[edit | edit source]
The main indication is application as an anticonception. Long-term applications can also be used for long-term ovarian suppression, for example in the case of endometriosis. They have no effect on inducing abortion. The toxicity of progestins is low, although they may cause an increase in blood pressure and a decrease in HDL.
Synthetic steroids are also used as oral contraceptives – 17alpha-hydroxyprogesterone and 17alpha-alkyl- substituted derivatives of 19-nortestosterone, medroxyprogesterone acetate (Provera), etc. The inhibitory effect on cell growth is used to treat differentiated endometrial cancer.
Sources[edit | edit source]
Related articles[edit | edit source]
References[edit | edit source]
- MARTÍNKOVÁ, Jiřina – MIČUDA, Stanislav – ČERMÁKOVÁ, Jolana. Vybrané kapitoly z klinické farmakologie pro bakalářské studium : Antikoncepce [online]. ©2001. [cit. 2010-07-09]. <https://www.lfhk.cuni.cz/farmakol/predn/bak/kapitoly/hormony/antikoncepce-bak.doc/>.
- MATOUŠ, Bohuslav. Základy lékařské chemie a biochemie. 1. edition. Praha : Galén, 2010. 540 pp. ISBN 978-80-7262-702-8.
- MURRAY, Robert K. Harperova biochemie. 2. edition. Jinočany : H&H, 2002. 871 pp. ISBN 80-7319-013-3.
- LEDVINA, Miroslav – STOKLASOVÁ, Alena – CERMAN, Jaroslav. Biochemie pro studující medicíny. 2. edition. Praha : Karolinum, 2009. 0 pp. ISBN 80-246-0851-0.
| This article is a stub.|
You can join the authors and edit it. You can discuss the changes at discussion.